Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02260596 · ClinicalTrials.gov registry record
Respiratory Viral Infections in Pediatric Transplantation
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 2,669
- Enrollment target
NCT02260596 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 2,669 participants.
The verdict
NCT02260596 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 2,669 participants
- Enrollment target
Study Summary
A retrospective cohort of solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients will be assembled to determine the incidence of respiratory viral infections diagnosed during an inpatient admission in the first year post-transplant. A sub-cohort of patients that develop a respiratory viral infection within one year of transplantation will be leveraged to investigate factors associated with mortality in the three months after respiratory viral infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,669 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02260596
The ClinicalTrials.gov registry entry for NCT02260596 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,669 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02260596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02260596 about?
NCT02260596 is a clinical study titled "Respiratory Viral Infections in Pediatric Transplantation". A retrospective cohort of solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients will be assembled to determine the incidence of respiratory viral infections diagnosed during an inpatient admission in the first year post-transplant. A sub-cohort of patients that develo...
What is the current status of trial NCT02260596?
This trial is currently completed. The enrollment target is 2,669 participants. The study started on 2014-09. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT02260596?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.